Sanofi has won FDA approval for its sutimlimab for cold agglutinin ... kidney disease (ADPKD) as well as Principia-partnered BTK inhibitor rilzabrutinib for rare autoimmune skin disease pemphigus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback